phrykt

Lemaitre Vascular Inc (LMAT): who owns it and who trades it

As of Nov 16, 2026, LMAT insiders reported 11 open-market sales worth $30M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was George W LeMaitre (CEO), with $27.1M. 5 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Lemaitre Vascular

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns LMAT

324 funds and institutions reported LMAT shares worth $2.2B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 14.3%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.14.3%
Conestoga Capital Advisors, LLC6.0%
First Trust Advisors LP4.8%
Congress Asset Management Co4.2%
Vanguard Capital Management LLC4.2%
State Street Corp3.9%
Copeland Capital Management, LLC3.7%
Geode Capital Management, LLC3.5%
T. Rowe Price Associates3.3%
Vanguard Portfolio Management LLC2.6%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.3.27M14.32%$314M+4%
Conestoga Capital Advisors, LLC1.37M5.98%$131M-7%
First Trust Advisors LP1.09M4.79%$105M+10%
Congress Asset Management Co963,7064.22%$92.5M+15%
Vanguard Capital Management LLC953,4374.17%$91.5M+5%
State Street Corp901,4163.94%$86.5M+5%
Copeland Capital Management, LLC839,4633.67%$80.6M-4%
Geode Capital Management, LLC788,8353.45%$75.7M+20%
T. Rowe Price Associates755,1423.30%$72.5M+156%
Vanguard Portfolio Management LLC604,8332.65%$58M+7%
Geneva Capital Management LLC589,0642.58%$56.5M-22%
Dimensional Fund Advisors LP493,8892.16%$47.4M+4%
Goldman Sachs Group Inc473,1942.07%$45.4M+9%
Invesco Ltd.448,3891.96%$43M+34%
Morgan Stanley351,0831.54%$33.7M-14%
Northern Trust Corp333,3251.46%$32M+7%
Two Sigma Investments, LP316,5281.39%$30.4M+12%
Royal Bank of Canada308,7651.35%$29.6M+13%
Annex Advisory Services, LLC248,2531.09%$23.8M-1%
UBS Group AG247,8041.08%$23.8M+498%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, LMAT insiders reported $0 of open-market purchases and $30M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$30M
11 trades, 5 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
May 8, 2026
Filed May 11, 2026

Purchases and sales by month

$17M$17MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
May 8, 2026George W LeMaitreCEOSale27,881$108.69$3MForm 4
May 8, 2026Trent G KamkeSenior V. P.Sale2,928$107.00$313KForm 4
May 7, 2026George W LeMaitreCEOSale18,600$107.64$2MForm 4
May 7, 2026Bridget A RossDirectorSale5,044$111.10$560KForm 4
May 7, 2026Lawrence J JasinskiDirectorSale3,943$110.00$434KForm 4
Mar 11, 2026Trent G KamkeSenior V. P.Sale2,625$108.50$285KForm 4
Mar 11, 2026David B RobertsPresidentSale3,312$107.68$357KForm 4
Mar 2, 2026George W LeMaitreCEOSale55,930$107.81$6MForm 4
Feb 27, 2026Trent G KamkeSenior V. P.Sale1,044$110.29$115KForm 4
Feb 27, 2026David B RobertsPresidentSale8,464$106.80$904KForm 4
Feb 26, 2026George W LeMaitreCEOSale150,000$106.76$16MForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
George W LeMaitreChairman and CEO, Director–$27.1MMay 8, 2026
David B RobertsPresident and Director, Director–$1.3MMar 11, 2026
Trent G KamkeSenior V. P., Operations–$713KMay 8, 2026
Bridget A RossDirector–$560KMay 7, 2026
Lawrence J JasinskiDirector–$434KMay 7, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

LMAT short interest

Moderate short interest. 7.2% of LMAT shares are sold short: about 1 share in 14. Over the last 12 reports the number of shares short went up 44%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 1.66M LMAT shares were sold short, 7.2% of the shares outstanding, down 6.7% from the report before. At the average daily volume of 268,701 shares, buying them all back would take about 6.2 trading days (days to cover).

Shares short, % of all shares

7.24%May 15Oct 308.17%

Days to cover

6.2May 15Oct 307.5

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.66M7.24%-7%268,7016.2
Oct 15, 20261.78M7.77%+2%270,3916.6
Sep 30, 20261.74M7.60%+3%253,2316.9
Sep 15, 20261.69M7.40%+11%268,4256.3
Aug 31, 20261.52M6.65%-5%318,1094.8
Aug 14, 20261.61M7.04%+11%585,9952.8
Jul 31, 20261.45M6.33%-2%258,6835.6
Jul 15, 20261.48M6.48%+9%328,7224.5
Jun 30, 20261.36M5.94%+6%408,2673.3
Jun 15, 20261.28M5.59%+8%292,2504.4
May 29, 20261.19M5.20%+3%318,4653.7
May 15, 20261.15M5.05%-1%309,9333.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Lemaitre Vascular company events

Lemaitre Vascular filed 7 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026ResultsReleased financial results. Filing
  2. Oct 15, 2026LeadershipDavid B. Roberts notified LeMaitre Vascular, Inc. of his intent to retire as an employee of the Company, including as its President, effective as of December 31, 2026. Filing
  3. Aug 4, 2026ResultsReleased financial results. Filing
  4. Jun 5, 2026VoteReported shareholder vote results. Filing
  5. May 5, 2026ResultsReleased financial results. Filing
  6. Apr 14, 2026LeadershipBridget Ross notified the Board of Directors of LeMaitre Vascular, Inc. of her intent not to stand for re-election as a Class II director of the Company at the Company’s 2026 Annual Meeting of Stockholders to be held on June 2, 2026. Filing
  7. Feb 25, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Lemaitre Vascular financials

Famous investors that hold LMAT

5 of the 50 well-known investors we track reported holding LMAT in their latest 13F filing. The largest position is Ken Griffin's, worth $50M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026605,346$50M0.0%+1313%
Steve Cohen · Point72 Asset ManagementQ3 202675,987$6.3M0.0%New
Paul Tudor Jones · Tudor Investment CorpQ3 202640,897$3.4M0.0%-54%
Israel Englander · Millennium ManagementQ3 202615,594$1.3M0.0%+73%
Jim Simons · Renaissance TechnologiesQ3 202611,602$958K0.0%-93%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Lemaitre Vascular Inc (LMAT) stock

Who owns the most LMAT stock?

The largest reported owner of Lemaitre Vascular Inc (LMAT) is BlackRock, Inc., with 14.3% of the company. In total, 324 funds and institutions reported holding LMAT at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are LMAT insiders buying or selling?

In the last 12 months, LMAT insiders reported no open-market purchases and 11 sales worth $30M. The latest trade was on May 8, 2026. See every trade.

What is the short interest in LMAT?

As of Oct 30, 2026, 1.66M LMAT shares were sold short, 7.2% of the shares outstanding, down 6.7% from the report before. At the average daily volume of 268,701 shares, buying them all back would take about 6.2 trading days (days to cover). See the history.

Which famous investors hold LMAT?

5 of the 50 well-known investors we track reported LMAT in their latest 13F filing, including Ken Griffin, Steve Cohen, Paul Tudor Jones. The largest position is worth $50M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.